Related Experiment Video
Updated: Jul 18, 2026
09:25
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Complementary treatments for tobacco cessation: a survey
Amit Sood1, Jon O Ebbert, Richa Sood
1Mayo Clinic College of Medicine, Rochester, MN 55905, USA. sood.amit@mayo.edu
Summary
Many tobacco users utilize complementary and alternative medicine (CAM) for cessation, with a significant interest in future use. Further research into these CAM therapies is warranted.
Area of Science:
- Public Health
- Behavioral Science
- Integrative Medicine
Background:
- Limited data exists on complementary and alternative medicine (CAM) use for tobacco cessation among tobacco users.
- Understanding patient interest in CAM is crucial for developing comprehensive cessation programs.
Purpose of the Study:
- To determine the prevalence of CAM use for tobacco cessation.
- To assess patient interest in future CAM use for tobacco cessation.
- To identify characteristics associated with past and future CAM use.
Main Methods:
- Anonymous, self-administered survey of 1,175 patients at a Midwestern tobacco treatment clinic.
- Data collected on past CAM use, perceived efficacy, and future interest in CAM therapies.
- Descriptive statistics and logistic regression analysis were employed.
Main Results:
- 27% of patients reported prior CAM use for tobacco cessation; common methods included hypnosis, relaxation, acupuncture, and meditation.
- 67% expressed interest in future CAM use; hypnosis, herbal products, acupuncture, relaxation, and massage therapy were most desired.
- Female gender, prior use of conventional cessation aids, previous CAM use, and higher education were linked to future CAM interest.
Conclusions:
- A substantial proportion of tobacco users have used or are interested in using CAM for cessation.
- The findings highlight the need for further research into the efficacy of CAM for tobacco cessation.
- Healthcare providers should consider discussing CAM options with patients seeking to quit smoking.
Related Concept Videos
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...